1) Wegener F. Über generalisierte, septische Gefässerkrankungen. Verh Dtsch Pathol Ges 1936 29:202–9. German.
2) Srouji I, Andrews P, Edwards C, Lund VJ. Patterns of presentation and diagnosis of patients with Wegener’s granulomatosis: ENT aspects. J Laryngol Otol 2007;121(7):653–8.
3) Xiao F, Lü W, Ni D, Yu H. [Misdiagnosis analysis of Wegener’s granulomatosis in otorhinolaryngology]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005 19(7):295–6. Chinese.
4) Park KT, Kong IG, Han DH, Kim DW, Kim SH, Rhee CS, et al. Clinical experiences of diagnosis and treatment for Wegener’s granulomatosis. Korean J Otorhinolaryngol-Head Neck Surg 2008;51(12):1109–18.
5) Lloyd G, Lund VJ, Beale T, Howard D. Rhinologic changes in Wegener’s granulomatosis. J Laryngol Otol 2002;116(7):565–9.
6) Trimarchi M, Sinico RA, Teggi R, Bussi M, Specks U, Meroni PL. Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener's). Autoimmun Rev 2013;12(4):501–5.
7) Holle JU, Gross WL, Holl-Ulrich K, Ambrosch P, Noelle B, Both M, et al. Prospective long-term follow-up of patients with localised Wegener’s granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 2010;69(11):1934–9.
10) Gottschlich S, Ambrosch P, Kramkowski D, Laudien M, Buchelt T, Gross W, et al. Head and neck manifestations of Wegener’s granulomatosis. Rhinology 2006;44(4):227–33.
11) Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 1990;33(8):1101–7.
12) Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010;363(3):211–20.
13) Lutalo PM, D’Cruz DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis). J Autoimmun 2014;48-49:94–8.
15) Seo P, Stone JH. The antineutrophil cytoplasmic antibody–associated vasculitides. Am J Med 2004;117(1):39–50.